Xcout Intel
ADAPTIN BIO, INC.
Adaptin Bio is a biotechnology company developing a proprietary drug delivery platform designed to enhance the transfer of therapeutics across biological barriers into the brain and other targeted tissues. Its lead technology, the Brain Bispecific T cell Engager (BRiTE) platform, manipulates the human immune system to target diseases in oncology, central nervous system disorders, autoimmune conditions, and cardiovascular markets.
Subscribe to see ADAPTIN BIO, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADAPTIN BIO, INC. at a glance
ADAPTIN BIO, INC. is a biotech company headquartered in United States. Xcout tracks 15 named people at ADAPTIN BIO, INC., including Michael J. Roberts (President and Chief Executive Officer).
ADAPTIN BIO, INC. leadership
- Michael J. RobertsPresident and Chief Executive Officer
- Timothy L. Maness, CPAChief Financial Officer
- L. Arthur Hewitt, Ph.D.Chief Development Officer
- Simon Pedder, Ph.D.Executive Chairman
- Michael J. Roberts, Ph.D.Co-Founder and CEO
- L. Arthur HewittExecutive Officer
9 more named people on record for ADAPTIN BIO, INC., with roles, board committees and tenure — see the full roster →
Recent ADAPTIN BIO, INC. news
Get ADAPTIN BIO, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ADAPTIN BIO, INC. in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access